Table of Contents

Stevens-Johnson syndrome

Stevens-Johnson syndrome (SJS) is a rare but serious disorder that affects the skin and mucous membranes.

Key Characteristics

Flu-like symptoms (fever, sore throat, fatigue) appear first.

Followed by a painful red or purplish rash that spreads and blisters.

Skin starts to peel, and large areas may slough off.

Mucous membranes (eyes, mouth, genital area) are often severely affected.

Etiology

It is usually triggered by a reaction to medication or, less commonly, by an infection. SJS is considered part of a spectrum with toxic epidermal necrolysis (TEN)—SJS being the milder form and TEN the more severe.

Medications: Most commonly sulfa antibiotics, anticonvulsants (like lamotrigine), allopurinol, NSAIDs, etc.

Infections: Especially Mycoplasma pneumoniae in children and young adults.

In some cases, the cause remains unknown.

Adverse Reactions to COVID-19 Vaccination 1).

Differential diagnosis

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare, severe skin reactions, usually triggered by medications or infections. They are considered different levels of the same disease spectrum.

Medical Emergency: Both SJS and TEN require hospitalization, often in burn or intensive care units.

Causes

Symptoms

Comparison Table

Feature Stevens-Johnson Syndrome (SJS) Toxic Epidermal Necrolysis (TEN)
Skin detachment <10% of body surface area (BSA) >30% of BSA
Overlap form Not applicable SJS/TEN overlap: 10–30% BSA
Severity Severe Life-threatening
Mortality rate ~5–10% ~30–50%
Treatment Stop causative drug, supportive care Same, but more intensive (ICU/Burn Unit)

Management

Long-Term Complications

<folded|Click to expand: Possible long-term effects>

</folded>

References


sjs_ten_dermatology_emergency_neuro_wiki

Treatment

Immediate discontinuation of the suspected causative drug.

Supportive care, often in an intensive care unit or burn unit.

Wound care, fluid and electrolyte management, pain control, and prevention of secondary infections.

Sometimes immunosuppressive therapies (e.g., corticosteroids, IVIG, or cyclosporine) are used, although evidence is mixed.

Prognosis

Mortality: ~5–10% for SJS, up to 30–50% for TEN.

Long-term complications can include chronic skin issues, ocular damage (e.g., blindness), and genital or oral scarring.

Neurosurgery

Case reports

A 65-year-old female who had come to the hospital with complaints of Sloughing of the skin and redness all over the body with raised body temperature. She was on therapeutic Phenytoin to prevent the post-surgical complications of Communicating Hydrocephalus. After a detailed examination, it was found that the patient had been misemployed with an overdose of Phenytoin. The patient was found with nikolsky sign and diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrosis overlap. This case report emphasizes phenytoin-induced Stevens-Johnson syndrome and Toxic Epidermal Necrosis syndrome exacerbated by cephalexin.

Practice implications: By witnessing this phenomenon, we could figure out the association between cephalexin and Stevens-Johnson syndrome- Toxic Epidermal Necrosis syndrome overlap. The immediate dismissal of the offending agent and commencement of supportive care was found to be effective 2).

1)
Battaglini D, Ball L, Robba C, Maiani S, Brunetti I, Benedetti L, Castellan L, Zona G, Pesce G, Rocco PRM, Pelosi P. Patients With Suspected Severe Adverse Reactions to COVID-19 Vaccination Admitted to Intensive Care Unit: A Case Report. Front Med (Lausanne). 2022 Mar 18;9:823837. doi: 10.3389/fmed.2022.823837. PMID: 35372434; PMCID: PMC8972056.
2)
Rathinam KK, Sabarathinam S, Nuthalapati P, Mahalingam VT. Phenytoin Induced Stevens Johnson Syndrome- Toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-Old Neurosurgical Patient: A Rare Case Report. Curr Drug Res Rev. 2021 Mar 22. doi: 10.2174/2589977513666210322160009. Epub ahead of print. PMID: 34225642.